The Very Latest in Cosmetic Chemistry

RevivSerums.com launches TelomErase Triple Telomere Targeting Serum.

The Luxonomist. 21/10/2015

RevivSerums.com, a San Francisco-based global leader in cosmetic chemistry innovation, introduces a first-of-its-kind skincare cosmetic topical, TelomErase Triple Telomere Targeting Serum. A conference by Nobel laureate Dr. Elizabeth Blackburn at the recent American Academy of Dermatology conclave in San Francisco underlined the clear correlation between the length and integrity of telomeres (DNA strand endcaps) with overall health & skin condition. TelomErase Serum combines three novel components known to target the support of those structures: Cycloastragenol, Telosomyl and Renovage.

RevivSerums 1
TelomErase Triple Telomere Targeting Serum. Click to buy

A unique 6-in-1 multi-corrective formula, TelomErase also blends instant, short and long-term acting ingredients into a single serum that can visibly reduce the appearance of sags & bags, dark circles, fine lines, sunspots, redness, pore size & laxity without irritation, downtime or acclimation concerns.

RevivSerums 3
RevivSerums Ultimate Serum. Click to buy

«Over a year in development, TelomErase Serum is the very latest in cosmetic chemistry,» said Vance Nesbitt, Director of ‘Lotions and Potions’ for RevivSerums. «It’s the greatest combination of hard-to-source ingredients blending instant-working bioactives along with long-term anti-aging components. Our customers have been asking for such a multi-corrective, at a reasonable price, and we think they’ll be elated with the results.»

In a 30-day, 22-person consumer study of TelomErase, over 90% of consumers tested noted a reduction in the appearance of skin laxity & skin roughness, 88% agreed that the area around the eye appeared improved; 74% of testers also saw a reduction in the appearance of redness and large pores, and 90% agreed that it made their skin more soft or smooth.

Subir arriba

Este sitio utiliza cookies para prestar sus servicios y analizar su tráfico. Las cookies utilizadas para el funcionamiento esencial de este sitio ya se han establecido.

MÁS INFORMACIÓN.

ACEPTAR
Aviso de cookies
Versión Escritorio